Reto Wittwer combines extensive financial expertise with a global outlook, backed by over 25 years of experience in the healthcare industry. As a seasoned board member and CFO, he has a demonstrated history of fostering growth and generating value in the pharmaceutical sector. He is a co-founder of DiNAQOR and currently serves on its Board of Directors as CFO. His career features executive roles at Sandoz, where he was SVP & CFO for North America, and at Novartis, where he held positions as VP & CFO for NIBR and as Global Head of Tax. Reto spent the first decade of his career at PwC and Deloitte. He holds a MLaw from the University of Zurich, an Executive MBL from the University of St. Gallen, and completed executive education at Harvard Business School.
